HMSH6: A potential diagnostic marker for oral carcinoma in situ

Journal of Clinical Pathology

Volumn 68, Issue 1, 2015, Pages 86-90

  Jessri, Maryam ^a   Dalley, Andrew J ^a   Farah, Camile S ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b Australian Centre for Oral Oncology Research and Education   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HETERODIMER; MISMATCH REPAIR PROTEIN PMS2; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6; PROTEIN MUTL; PROTEIN MUTS; DNA BINDING PROTEIN; G-T MISMATCH-BINDING PROTEIN; TUMOR MARKER;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CANCER DIAGNOSIS; CARCINOMA IN SITU; CONTROLLED STUDY; DISEASE SEVERITY; DYSPLASIA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MISMATCH REPAIR; MOUTH DYSPLASIA; MOUTH SQUAMOUS CELL CARCINOMA; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; BIOSYNTHESIS; MIDDLE AGED; MOUTH NEOPLASMS;

ADULT; CARCINOMA IN SITU; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOUTH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84919341549     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2014-202411     Document Type: Article

References (14)

1. Benachenhou N, Guiral S, Gorska-Flipot I, et al. High resolution deletion mapping reveals frequent allelic losses at the DNA mismatch repair loci hMLH1 and hMSH3 in non-small cell lung cancer. Int J Cancer 1998;77:173-80
2. Fishel R, Wilson T. MutS homologs in mammalian cells. Curr Opin Genet Dev 1997;7:105-13
3. Modrich P, Lahue R. Mismatch repair in replication fidelity, genetic recombination, and cancer biology. Annu Rev Biochem 1996;65:101-33
4. Dost F, Lê Cao K, Ford PJ, et al. Malignant transformation of oral epithelial dysplasia: A real-world evaluation of histopathologic grading. Oral Surg Oral Med Oral Pathol Oral Radiol 2014;117:343-52
5. Kujan O, Oliver RJ, Khattab A, et al. Evaluation of a new binary system of grading oral epithelial dysplasia for prediction of malignant transformation. Oral Oncol 2006;42:987-93
6. Koutsimpelas D, Pongsapich W, Heinrich U, et al. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells. Oncol Rep 2012; 27:1135-41
7. Sengupta S, Chakrabarti S, Roy A, et al. Inactivation of human MutL homolog 1 and MutS homolog 2 genes in head and neck squamous cell carcinoma tumors and leukoplakia samples by promoter hypermethylation and its relation with microsatellite instability phenotype. Cancer 2007;109:703-12
8. Lo Muzio L, Nocini P, Mignogna MD, et al. Immunocytochemical detection of hMSH2 and hMLH1 expression in oral SCC. Anticancer Res 1999; 19:933-40
9. Tawfik HM, El-MaqsoudNMRA, Hak BHAA, et al. Head and neck squamous cell carcinoma: Mismatch repair immunohistochemistry and promoter hypermethylation of hMLH1 gene. Am J Otolaryngol 2011;32:528-36
10. Caldeira PC, Aguiar MCF, Mesquita RA, et al. Oral leukoplakias with different degrees of dysplasia: Comparative study of hMLH1, p53, and AgNOR. J Oral Pathol Med 2011;40:305-11
11. Caldeira PC, Abreu MHNG, Batista AC, et al. hMLH1 immunoexpression is related to the degree of epithelial dysplasia in oral leukoplakia. J Oral Pathol Med 2011;40:153-59
12. Barnes L, Eveson JW, Reichart P, et al. World Health Organization Classification of Tumours. Pathology and Genetics of Head and Neck Tumours. 9th edn. Lyon: IARC Press, 2005
13. Czerninski R, Krichevsky S, Ashhab Y, et al. Promoter hypermethylation of mismatch repair genes, hMLH1 and hMSH2 in oral squamous cell carcinoma. Oral Dis 2009;15:206-13
14. Jessri M, Dalley AJ and Farah CS. MutSa and MutLa immunoexpression analysis in diagnostic grading of oral epithelial dysplasia and squamous cell carcinoma. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology Published Online First: 25 Sep 2014